title: Isoforms of cathepsin D and human epidermal differentiation.
abstract: Cathepsin D is an ubiquitously expressed lysosomal aspartic proteinase, with well-determined structural and chemical properties but a less clearly defined biological role. In stratified epithelia, the chronology of cathepsin D activation and degradation can be connected with stages of cellular differentiation. We partially purified cathepsin D from human epidermis and from separated stratum corneum by standard biochemical procedures, monitored by SDS-PAGE and Western blotting, and verified its identity as to molecular mass, pH optimum, N-terminal sequencing, reactivity with the specific antibody, inhibition by pepstatin A, and specific enzyme activity. It had hemoglobin-degrading activity over the acid range, with maximum at pH 3. It also degraded bovine serum albumin, human keratins, and stratum corneum extracts at pH 4. We discerned all three isoforms of human cathepsin D (the 52 kDa proenzyme and the active forms at 48 kDa and 33 kDa) in the epidermis; both active forms were also seen in the stratum corneum, but the proenzyme was not. Gene expression of cathepsin D in epidermal keratinocytes resembled that of suprabasal structural proteins (involucrin, keratin K10, transglutaminase) in its response to the calcium switch. An antibody to the 33 kda isoform immunolocalized to the granular layer and the stratum corneum (whereas antibodies to the 48 kDa isoform have been reported to stain mainly the upper spinous and granular layers). A plausible hypothesis to harmonize these results is that cathepsin D is first expressed as the proenzyme in the upper spinous layer, is activated in the lysosomes in the granular layer to the 48 kDa form, and is degraded to the 33 kDa form in the transition zone between the granular layer and the stratum corneum. As the stratum corneum is an acid environment, with an ambient pH of approximately 4.5, cathepsin D is available and suited to contribute to desquamation.
authors.affiliation: Department of Dermatology, University of Texas Medical Branch, Galveston 77555, USA.
authors.forename: T
authors.initials: T
authors.lastname: Horikoshi
authors.forename: I
authors.initials: I
authors.lastname: Arany
authors.forename: S
authors.initials: S
authors.lastname: Rajaraman
authors.forename: S H
authors.initials: SH
authors.lastname: Chen
authors.forename: H
authors.initials: H
authors.lastname: Brysk
authors.forename: G
authors.initials: G
authors.lastname: Lei
authors.forename: S K
authors.initials: SK
authors.lastname: Tyring
authors.forename: M M
authors.initials: MM
authors.lastname: Brysk
mesh_terms: D000595:Amino Acid Sequence; D002402:Cathepsin D / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D002454:Cell Differentiation; D002478:Cells, Cultured; D000078404:Epidermal Cells; D004817:Epidermis / Q000201:enzymology; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D007150:Immunohistochemistry; D007527:Isoenzymes / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*
chemical_list: D007527:Isoenzymes; D002402:Cathepsin D